Related Experiment Video
Updated: Feb 13, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease
Meredith A Baker1, Paul D Mitchell2, Alison A O'Loughlin1
1Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
Insights
Reduced soybean oil (SO) doses in parenteral nutrition for infants with liver disease altered fatty acid profiles but did not cause essential fatty acid deficiency. These findings impact infant nutrition and liver disease management.
Area of Science:
- Pediatric Gastroenterology
- Nutritional Science
- Neonatology
Background:
- Infants with intestinal failure-associated liver disease (IFALD) often require parenteral nutrition (PN).
- Soybean oil-based lipid emulsions (SO) are commonly used in PN but can affect fatty acid profiles (FAPs).
- Understanding FAPs is crucial for managing IFALD in PN-dependent infants.
Purpose of the Study:
- To characterize fatty acid profiles (FAPs) in PN-dependent infants with IFALD.
- To compare FAPs in infants receiving standard doses (SO-S) versus reduced doses (SO-R) of soybean oil-based lipid emulsions.
- To assess the impact of different SO doses on essential fatty acid deficiency (EFAD) in this population.
Main Methods:
- Retrospective review of prospectively collected data from infants (<1 year old) with IFALD receiving PN with SO.
- Analysis of serum fatty acid profiles before transitioning to fish oil-based lipid emulsion.
- Comparison of demographics, anthropometrics, SO dose, duration of SO use, and FAPs between SO-S and SO-R groups.
Main Results:
- No demographic or anthropometric differences between SO-S (n=14) and SO-R (n=35) groups.
- SO-R group showed significantly higher Mead acid and lower levels of α-linolenic, eicosapentaenoic, linoleic, stearic, total ω-3, and total ω-6 fatty acids compared to SO-S group (P < .01).
- Higher triene:tetraene ratios in the SO-R group (P = .0009), with no patients experiencing biochemical EFAD.
Conclusions:
- Reduced soybean oil doses in PN for infants with IFALD result in distinct fatty acid profiles compared to standard doses.
- No infants in either the standard or reduced SO dose group exhibited biochemical essential fatty acid deficiency.
- These findings suggest careful monitoring of FAPs is warranted when adjusting SO dosage in PN for IFALD.
Background:
The purpose of this study was to characterize fatty acid profiles (FAPs) in parenteral nutrition (PN)-dependent infants with intestinal failure-associated liver disease (IFALD) receiving soybean oil-based lipid emulsion (SO) doses of ∼3 and ∼1 g/kg/d.
Methods:
Prospectively collected data were retrospectively reviewed. Serum FAPs of patients <1 year old who experienced development of IFALD while receiving standard PN with SO were examined before transitioning to a fish oil-based lipid emulsion for IFALD treatment. Time on SO, dose, gestational age, and weight- and length-for-age z scores were also reviewed.
Results:
Among the 49 patients analyzed, there were no differences in demographics or anthropometrics between patients who received standard SO (SO-S) (n = 14, range of dosage 2.06-3.31 g/kg/d) and reduced SO (SO-R) (n = 35, range of dosage 0.90-1.34 g/kg/d). Patients received SO for a median of 53 days (interquartile range 39, 73) before FAP measurement. Patients who received SO-R had significantly higher Mead acid and lower α-linolenic, eicosapentaenoic, linoleic, stearic, total ω-3, and total ω-6 fatty acid levels than patients who received SO-S (P < .01). Triene:tetraene ratios were higher in patients who received SO-R (P = .0009), and no patients experienced biochemical essential fatty acid deficiency (EFAD).
Conclusion:
PN-dependent infants with IFALD receiving SO-R have different FAPs than patients receiving SO-S. No patients in either group had biochemical EFAD.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Drug Dosing: Infants and Children